GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
H

Huadong Medicine Co 000963.SZ · CNY

Health Care · Shenzhen · 🇨🇳 China

Compare

27.05

-2.42%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Huadong Medicine Co

Its shares trade on Shenzhen under the ticker 000963.SZ. It has been listed since 27 January 2000. In the fiscal year to 31 December 2025, it reported revenue of CN¥43.61bn and net income of CN¥3.41bn. At that date it held total assets of CN¥39.04bn and shareholders' equity of CN¥24.81bn.

Huadong Medicine Co., Ltd. engages in the production and sale of antibiotics, proprietary Chinese medicine, chemical synthetic medicine, and genetic engineering drugs. The company is headquartered in Hangzhou, Zhejiang. The company went IPO on 2000-01-27. The firm is mainly engaged in the research and development of pharmaceuticals, the production and sales of chemical drugs, bulk drugs and preparations of traditional Chinese medicine, the distribution and retails of pharmaceuticals, medicine modern logistics, health industry, and the manufacturing and sales of medical beauty products. The firm's products principally include Chinese patent drugs, immunosuppressive agents, endocrine drugs, digestive system drugs, antineoplastic drugs, cardiovascular drugs and antibiotic drugs. The firm distributes its products in domestic market and to overseas markets.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Providers & Services
Listed since
27 Jan 2000
Employees
12,427

Leadership

Pay as last reported

  • Mr. Liang LuChairman of the Board, General Manager, since 2010CN¥2.4m
  • Mr. Renbo QiuFinance DirectorCN¥1.3m
  • Mr. Hui WuDeputy General ManagerCN¥1.4m
  • Mr. Jianfei ZhangDeputy General ManagerCN¥1.4m
  • Ms. Li ZhuDeputy General ManagerCN¥1.4m
  • Mr. Bo ChenSecretary of the BoardCN¥1.3m
  • Ms. Wei KangDirectorCN¥30,000
  • Mr. Yang WangDirectorCN¥13,600
  • Mr. Bo YeDirectorCN¥30,000
  • Mr. Feipeng ZhuDirectorCN¥30,000
  • Mr. Liang ZhuDirectorCN¥650,000
  • Ms. Xiangdong GaoIndependent DirectorCN¥100,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
74
Environment
72
Social
72
Governance
79
Direct emissions (scope 1)
15,594.79 t
Energy emissions (scope 2)
171,359.01 t
Carbon reduction policy
Yes
Human rights policy
Yes

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.